Leveron&Nexovas
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 887  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
Read this article

 


    Article Cited by others

REVIEW ARTICLE

Dysferlinopathies

Urtizberea J Andoni, Bassez Guillaume, Leturcq France, Nguyen Karine, Krahn Martin, Levy Nicolas

Year : 2008| Volume: 56| Issue : 3 | Page no: 289-297

   This article has been cited by
 
1 Dysferlinopathy, with mild cardiac involvement, from a novel mutation of DYSF gene
J Y Shen, K Prasad, L L Goh, S Angkodjojo, C Y Khoo, T Umapathi
QJM: An International Journal of Medicine. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 Dysferlinopathies: Clinical and genetic variability
Alisa Ivanova, Svetlana Smirnikhina, Alexander Lavrov
Clinical Genetics. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 The C2 domains of dysferlin: roles in membrane localization, Ca 2+ signalling and sarcolemmal repair
Joaquin Muriel, Valeriy Lukyanenko, Tom Kwiatkowski, Sayak Bhattacharya, Daniel Garman, Noah Weisleder, Robert J. Bloch
The Journal of Physiology. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Key biomarkers and latent pathways of dysferlinopathy: Bioinformatics analysis and in vivo validation
Yan Xie, Ying-hui Li, Kai Chen, Chun-yan Zhu, Jia-ying Bai, Feng Xiao, Song Tan, Li Zeng
Frontiers in Neurology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
5 Clinical, Neurophysiological, Radiological, Pathological, and Genetic Features of Dysferlinopathy in Saudi Arabia
Norah Alharbi, Rawan Matar, Edward Cupler, Hindi Al-Hindi, Hatem Murad, Iftteah Alhomud, Dorota Monies, Ali Alshehri, Mossaed Alyahya, Brian Meyer, Saeed Bohlega
Frontiers in Neuroscience. 2022; 16
[Pubmed]  [Google Scholar] [DOI]
6 Elevated Ca2+ at the triad junction underlies dysregulation of Ca2+ signaling in dysferlin-null skeletal muscle
Valeriy Lukyanenko, Joaquin Muriel, Daniel Garman, Leonid Breydo, Robert J. Bloch
Frontiers in Physiology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
7 A Novel Homozygous Variant in DYSF Gene Is Associated with Autosomal Recessive Limb Girdle Muscular Dystrophy R2/2B
Patrizia Spadafora, Antonio Qualtieri, Francesca Cavalcanti, Gemma Di Palma, Olivier Gallo, Selene De Benedittis, Annamaria Cerantonio, Luigi Citrigno
International Journal of Molecular Sciences. 2022; 23(16): 8932
[Pubmed]  [Google Scholar] [DOI]
8 Causative variants linked with limb girdle muscular dystrophy in an Iranian population: 6 novel variants
Hamidreza Mianesaz, Safoura Ghalamkari, Mansoor Salehi, Mahdiyeh Behnam, Majid Hosseinzadeh, Keivan Basiri, Majid Ghasemi, Maryam Sedghi, Behnaz Ansari
Molecular Genetics & Genomic Medicine. 2022;
[Pubmed]  [Google Scholar] [DOI]
9 A novel dysferlin gene mutation in a Filipino male with Miyoshi myopathy
Karen Joy Adiao, Mario B. Prado, Mina Astejada
Clinical Neurology and Neurosurgery. 2021; 201: 106433
[Pubmed]  [Google Scholar] [DOI]
10 Myositis mimics
Sujata Ganguly, Rudrarpan Chatterjee, Abhishek Zanwar, Latika Gupta
Indian Journal of Rheumatology. 2021; 16(4): 427
[Pubmed]  [Google Scholar] [DOI]
11 Subclinical Cardiomyopathy in Miyoshi Myopathy Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Imaging
Sarah Ming Li Tan, Ching Ching Ong, Kong Bing Tan, Hui-Lin Chin, Prakash R Paliwal, Kay Wei Ping Ng, Weiqin Lin
International Heart Journal. 2021; 62(1): 186
[Pubmed]  [Google Scholar] [DOI]
12 Prospects for the Etiotropic Treatment of Dysferlinopathy
Alisa V. Ivanova, Svetlana A. Smirnikhina, Alexander V. Lavrov
Annals of the Russian academy of medical sciences. 2021; 76(3): 307
[Pubmed]  [Google Scholar] [DOI]
13 Deep phenotyping of an international series of patients with late-onset dysferlinopathy
Gorka Fernández-Eulate, Giorgia Querin, Ursula Moore, Anthony Behin, Marion Masingue, Guillaume Bassez, Sarah Leonard-Louis, Pascal Laforêt, Thierry Maisonobe, Philippe-Edouard Merle, Marco Spinazzi, Guilhem Solé, Thierry Kuntzer, Anne-Laure Bedat-Millet, Emmanuelle Salort-Campana, Shahram Attarian, Yann Péréon, Leonard Feasson, Julie Graveleau, Aleksandra Nadaj-Pakleza, France Leturcq, Svetlana Gorokhova, Martin Krahn, Bruno Eymard, Volker Straub, Teresinha Evangelista, Tanya Stojkovic
European Journal of Neurology. 2021; 28(6): 2092
[Pubmed]  [Google Scholar] [DOI]
14 Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent
Samya Chakravorty, Babi Ramesh Reddy Nallamilli, Satish Vasant Khadilkar, Madhu Bala Singla, Ashish Bhutada, Rashna Dastur, Pradnya Satish Gaitonde, Laura E Rufibach, Logan Gloster, Madhuri Hegde
Frontiers in Neurology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
15 Myofibers deficient in connexins 43 and 45 expression protect mice from skeletal muscle and systemic dysfunction promoted by a dysferlin mutation
Gabriela Fernández, Guisselle Arias-Bravo, Jorge A. Bevilacqua, Mario Castillo-Ruiz, Pablo Caviedes, Juan C. Sáez, Luis A. Cea
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2020; 1866(8): 165800
[Pubmed]  [Google Scholar] [DOI]
16 Functions of Vertebrate Ferlins
Anna V. Bulankina, Sven Thoms
Cells. 2020; 9(3): 534
[Pubmed]  [Google Scholar] [DOI]
17 Early pathological signs in young dysf mice are improved by halofuginone
Hila Barzilai-Tutsch, Olga Genin, Mark Pines, Orna Halevy
Neuromuscular Disorders. 2020; 30(6): 472
[Pubmed]  [Google Scholar] [DOI]
18 The effects of concentric and eccentric training in murine models of dysferlin-associated muscular dystrophy
Morium Begam, Renuka Roche, Joshua J. Hass, Chantel A. Basel, Jacob M. Blackmer, Jasmine T. Konja, Amber L. Samojedny, Alyssa F. Collier, Sujay S. Galen, Joseph A. Roche
Muscle & Nerve. 2020; 62(3): 393
[Pubmed]  [Google Scholar] [DOI]
19 Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B
Stephanie L. Sellers,Nadia Milad,Zoe White,Chris Pascoe,Rayleigh Chan,Geoffrey W. Payne,Chun Seow,Fabio Rossi,Michael A. Seidman,Pascal Bernatchez
Journal of Lipid Research. 2018; 59(2): 261
[Pubmed]  [Google Scholar] [DOI]
20 Limb-Girdle Muscular Dystrophy 2B and Miyoshi Presentations of Dysferlinopathy
Nirupa J. Patel,Kenneth W. Van Dyke,Luis R. Espinoza
The American Journal of the Medical Sciences. 2017; 353(5): 484
[Pubmed]  [Google Scholar] [DOI]
21 Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies
Ana M. Cárdenas,Arlek M. González-Jamett,Luis A. Cea,Jorge A. Bevilacqua,Pablo Caviedes
Experimental Neurology. 2016; 283: 246
[Pubmed]  [Google Scholar] [DOI]
22 Respiratory and cardiac function in japanese patients with dysferlinopathy
Atsuko Nishikawa,Madoka Mori-Yoshimura,Kazuhiko Segawa,Yukiko K. Hayashi,Toshiaki Takahashi,Yuko Saito,Ikuya Nonaka,Martin Krahn,Nicolas Levy,Jun Shimizu,Jun Mitsui,En Kimura,Jun Goto,Naohiro Yonemoto,Masashi Aoki,Ichizo Nishino,Yasushi Oya,Miho Murata
Muscle & Nerve. 2016; 53(3): 394
[Pubmed]  [Google Scholar] [DOI]
23 Progress and challenges in diagnosis of dysferlinopathy
Marina Fanin,Corrado Angelini
Muscle & Nerve. 2016; 54(5): 821
[Pubmed]  [Google Scholar] [DOI]
24 The absence of dysferlin induces the expression of functional connexin-based hemichannels in human myotubes
Luis A. Cea,Jorge A. Bevilacqua,Christian Arriagada,Ana María Cárdenas,Anne Bigot,Vincent Mouly,Juan C. Sáez,Pablo Caviedes
BMC Cell Biology. 2016; 17(S1)
[Pubmed]  [Google Scholar] [DOI]
25 Myofiber Damage Precedes Macrophage Infiltration after in Vivo Injury in Dysferlin-Deficient A/J Mouse Skeletal Muscle
Joseph A. Roche,Mohan E. Tulapurkar,Amber L. Mueller,Nico van Rooijen,Jeffrey D. Hasday,Richard M. Lovering,Robert J. Bloch
The American Journal of Pathology. 2015; 185(6): 1686
[Pubmed]  [Google Scholar] [DOI]
26 AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models
Patricia C. Sondergaard,Danielle A. Griffin,Eric R. Pozsgai,Ryan W. Johnson,William E. Grose,Kristin N. Heller,Kim M. Shontz,Chrystal L. Montgomery,Joseph Liu,Kelly Reed Clark,Zarife Sahenk,Jerry R. Mendell,Louise R. Rodino-Klapac
Annals of Clinical and Translational Neurology. 2015; 2(3): 256
[Pubmed]  [Google Scholar] [DOI]
27 Diagnostic overview of blood-based dysferlin protein assay for dysferlinopathies
Arunkanth Ankala,Babi R Nallamilli,Laura E. Rufibach,Esther Hwang,Madhuri R. Hegde
Muscle & Nerve. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
28 Improved immunoblotting methods provide critical insights into phenotypic differences between two murine dysferlinopathy models
Amber L. Mueller,Patrick F. Desmond,Ru-ching Hsia,Joseph A. Roche
Muscle & Nerve. 2014; 50(2): 286
[Pubmed]  [Google Scholar] [DOI]
29 Exome sequencing as a second-tier diagnostic approach for clinically suspected dysferlinopathy patients
Marc Bartoli,Jean-Pierre Desvignes,Jean-Pierre BSc,Levy Nicolas,Krahn Martin
Muscle & Nerve. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
30 Lipid Accumulation in Dysferlin-Deficient Muscles
Miranda D. Grounds,Jessica R. Terrill,Hannah G. Radley-Crabb,Terry Robertson,John Papadimitriou,Simone Spuler,Tea Shavlakadze
The American Journal of Pathology. 2014; 184(6): 1668
[Pubmed]  [Google Scholar] [DOI]
31 New developments in exon skipping and splice modulation therapies for neuromuscular diseases
Aleksander Touznik,Joshua JA Lee,Toshifumi Yokota
Expert Opinion on Biological Therapy. 2014; 14(6): 809
[Pubmed]  [Google Scholar] [DOI]
32 Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/myoshi myopathy necessitates mutational screen for diagnosis
Mats I. Nilsson,Marissa L. Laureano,Munim Saeed,Mark A. Tarnopolsky
Muscle & Nerve. 2013; 47(5): 740
[Pubmed]  [Google Scholar] [DOI]
33 Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/myoshi myopathy necessitates mutational screen for diagnosis
Nilsson, M.I. and Laureano, M.L. and Saeed, M. and Tarnopolsky, M.A.
Muscle and Nerve. 2013; 47(5): 740-747
[Pubmed]  [Google Scholar]
34 Inhibition of muscle fibrosis and improvement of muscle histopathology in dysferlin knock-out mice treated with halofuginone
Halevy, O. and Genin, O. and Barzilai-Tutsch, H. and Pima, Y. and Levi, O. and Moshe, I. and Pines, M.
Histology and Histopathology. 2013; 28(2): 211-226
[Pubmed]  [Google Scholar]
35 A regional panorama of dysferlinopathies [Disferlinopatilerin bölgesel panoramasi{dotless
Diniz, G. and Eryaşar, G. and Türe, S. and Akçay, A. and Ortaç, R. and Tekgül, H. and Akhan, G.
Turk Patoloji Dergisi/Turkish Journal of Pathology. 2012; 28(3): 259-265
[Pubmed]  [Google Scholar]
36 Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies
Salani, S. and Donadoni, C. and Rizzo, F. and Bresolin, N. and Comi, G.P. and Corti, S.
Journal of Cellular and Molecular Medicine. 2012; 16(7): 1353-1364
[Pubmed]  [Google Scholar]
37 Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as anin vitromodel and for therapy of muscular dystrophies
Sabrina Salani,Chiara Donadoni,Federica Rizzo,Nereo Bresolin,Giacomo P. Comi,Stefania Corti
Journal of Cellular and Molecular Medicine. 2012; 16(7): 1353
[Pubmed]  [Google Scholar] [DOI]
38 Unmasking Potential Intracellular Roles For Dysferlin through Improved Immunolabeling Methods
Joseph A. Roche,Lisa W. Ru,Andrea M. O’Neill,Wendy G. Resneck,Richard M. Lovering,Robert J. Bloch
Journal of Histochemistry & Cytochemistry. 2011; 59(11): 964
[Pubmed]  [Google Scholar] [DOI]
39 Comparison of Dysferlin Expression in Human Skeletal Muscle with That in Monocytes for the Diagnosis of Dysferlin Myopathy
Eduard Gallardo,Noemi de Luna,Jordi Diaz-Manera,Ricardo Rojas-García,Lidia Gonzalez-Quereda,Bàrbara Flix,Antoine de Morrée,Silvère van der Maarel,Isabel Illa,Markus Schuelke
PLoS ONE. 2011; 6(12): e29061
[Pubmed]  [Google Scholar] [DOI]
40 UMD-DYSF, a novel locus specific database for the compilation and interactive analysis of mutations in the dysferlin gene
Dalil Hamroun, Brad Williams, Nilah Monnier, Laura E. Rufibach, Jon Andoni Urtizberea, Gaelle Blandin, Christophe Beroud, Veronique Labelle, Karine Nguyen, Nicolas Wein
Human Mutation. 2011; : n/a
[HTML Full text]  [Google Scholar] [DOI]
41 Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy
Gallardo, E. and de Luna, N. and Diaz-Manera, J. and Rojas-García, R. and Gonzalez-Quereda, L. and Flix, B. and de Morrée, A. and van der Maarel, S. and Illa, I.
PLoS ONE. 2011; 6(12)
[Pubmed]  [Google Scholar]
42 Unmasking Potential Intracellular Roles For Dysferlin through Improved Immunolabeling Methods
Roche, J.A. and Ru, L.W. and OæNeill, A.M. and Resneck, W.G. and Lovering, R.M. and Bloch, R.J.
Journal of Histochemistry and Cytochemistry. 2011; 59(11): 964-975
[Pubmed]  [Google Scholar]
43 Ferlin proteins in myoblast fusion and muscle growth
Posey Jr., A.D. and Demonbreun, A. and McNally, E.M.
Current Topics in Developmental Biology. 2011; 96: 203-230
[Pubmed]  [Google Scholar]
44 Dysferlinopathy: Spectrum of pathological changes in skeletal muscle tissue
Gayathri, N. and Alefia, R. and Nalini, A. and Yasha, T.C. and Anita, M. and Santosh, V. and Shankar, S.K.
Indian Journal of Pathology and Microbiology. 2011; 54(2): 350-354
[Pubmed]  [Google Scholar]
45 Novel ancestral Dysferlin splicing mutation which migrated from the Iberian peninsula to South America
Neuromuscular Disorders. 2011; 21(5): 328
[HTML Full text]  [Google Scholar] [DOI]
46 Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations
European Journal of Human Genetics. 2011;
[HTML Full text]  [Google Scholar] [DOI]
47 Exclusion of Mutations in the Dysferlin Alternative Exons 1 ofDYSF-v1, 5a, and 40a in a Cohort of 26 Patients
Martin Krahn,Véronique Labelle,Ana Borges,Marc Bartoli,Nicolas Lévy
Genetic Testing and Molecular Biomarkers. 2010; 14(1): 153
[Pubmed]  [Google Scholar] [DOI]
48 Diversification of muscle types: Recent insights from Drosophila
Vanessa Tixier,Laetitia Bataillé,Krzysztof Jagla
Experimental Cell Research. 2010; 316(18): 3019
[Pubmed]  [Google Scholar] [DOI]
49 Recessive Mutations in the Putative Calcium-Activated Chloride Channel Anoctamin 5 Cause Proximal LGMD2L and Distal MMD3 Muscular Dystrophies
Véronique Bolduc,Gareth Marlow,Kym M. Boycott,Khalil Saleki,Hiroshi Inoue,Johan Kroon,Mitsuo Itakura,Yves Robitaille,Lucie Parent,Frank Baas,Kuniko Mizuta,Nobuyuki Kamata,Isabelle Richard,Wim H.J.P. Linssen,Ibrahim Mahjneh,Marianne de Visser,Rumaisa Bashir,Bernard Brais
The American Journal of Human Genetics. 2010; 86(2): 213
[Pubmed]  [Google Scholar] [DOI]
50 Diversification of muscle types: Recent insights from Drosophila
Tixier, V. and Bataillé, L. and Jagla, K.
Experimental Cell Research. 2010; 316(18): 3019-3027
[Pubmed]  [Google Scholar]
51 Autosomal recessive limb-girdle muscular dystrophy [Distrofias musculares de cinturas autosómicas recesivas]
Hernández-Caballero, M.E. and Miranda-Duarte, A. and Escobar-Cedillo, R.E. and Villegas-Castrejón, H.
Revista de Neurologia. 2010; 51(8): 489-496
[Pubmed]  [Google Scholar]
52 Recessive Mutations in the Putative Calcium-Activated Chloride Channel Anoctamin 5 Cause Proximal LGMD2L and Distal MMD3 Muscular Dystrophies
Bolduc, V., Marlow, G., Boycott, K.M., Saleki, K., Inoue, H., Kroon, J., Itakura, M., Brais, B.
American Journal of Human Genetics. 2010; 86(2): 213-221
[Pubmed]  [Google Scholar]
53 Diaphragm displays early and progressive functional deficits in dysferlin-deficient mice
Elisabeth R. Barton, Bing Jing Wang, Becky K. Brisson, H. Lee Sweeney
Muscle & Nerve. 2010; 42(1): 22
[HTML Full text]  [Google Scholar] [DOI]
54 Exclusion of mutations in the dysferlin alternative exons 1 of DYSF-v1, 5a, and 40a in a cohort of 26 patients
Krahn, M., Labelle, V., Borges, A., Bartoli, M., Lévy, N.
Genetic Testing and Molecular Biomarkers. 2010; 14(1): 153-154
[Pubmed]  [Google Scholar]
55 Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping
Anthony Behin, Gillian Butler-Browne, Vincent Mouly, Martin Krahn, Nicolas Wein, Aurélie Avril, Marc Bartoli, Cyriaque Beley, Soraya Chaouch, Pascal Laforet
Human Mutation. 2010; 31(2): 136-142
[Pubmed]  [Google Scholar] [DOI]
56 Clinical and pathological analysis of limb-girdle muscular dystrophy type 2B misdiagnosed as polymyositis
Li, N. and Liu, Y.-L. and Li, Q.-X. and Yuan, J.-H. and Zhao, Z. and Shen, H.-R. and Hu, J.
Chinese Journal of Neurology. 2009; 42(9): 596-599
[Pubmed]  [Google Scholar]

 

Online since 20th March '04
Published by Wolters Kluwer - Medknow